St. John's Wort

St. John's Wort (Hypericum perforatum) is a yellow-flowered herb that's been used for low mood for centuries and is one of the most studied natural antidepressants in existence. The reason people reach for it is simple: for mild to moderate depression, the evidence puts it roughly on par with prescription SSRIs like sertraline or fluoxetine, with noticeably fewer side effects, no sexual dysfunction in most users, and no withdrawal of the kind people get coming off SSRIs. In Germany it's actually prescribed by doctors more often than fluoxetine for this exact reason.

The catch, and it's a serious one, is that St. John's Wort is one of the most aggressive natural drug interactors known. It speeds up the liver enzymes that metabolise roughly half of all prescription medications, including the contraceptive pill, blood thinners, immunosuppressants, HIV meds, some chemotherapy drugs, and most other antidepressants. If you take any prescription medication, you need to clear it with whoever prescribes that medication before starting St. John's Wort. If you're combining it with an SSRI or any other serotonergic drug (including tramadol or triptans for migraine), you risk serotonin syndrome, which can be life-threatening. So this isn't a casual addition to a stack. It's a real antidepressant with a real side effect profile.

Deep-dive

The plant contains dozens of bioactive compounds, but the two that get most of the attention are hyperforin and hypericin. Hyperforin is now considered the main driver of the antidepressant effect. It works through a genuinely unusual mechanism: rather than blocking specific monoamine transporters the way SSRIs do, it raises intracellular sodium concentrations, which non-competitively inhibits the reuptake of serotonin, dopamine, noradrenaline, GABA, and glutamate all at once. No other antidepressant has this broad reuptake-inhibiting profile. Hypericin contributes to a lesser extent and was historically thought to be the active ingredient, but the current evidence points more firmly at hyperforin.

On top of the reuptake inhibition, chronic dosing downregulates beta-1 adrenoceptors and upregulates 5-HT1A and 5-HT2 receptors, which is the same kind of slow receptor adaptation seen with conventional antidepressants and is part of why the effect takes 2-4 weeks to build. There's also some evidence the extract modulates membrane fluidity and lipid composition in ways that affect receptor signalling, which may explain why low-hyperforin extracts still work in some trials.

The efficacy evidence. The most rigorous summary remains the 2008 Cochrane review of 29 trials and 5,489 patients, which concluded that St. John's Wort extracts were superior to placebo, similar in effect to standard antidepressants, and had fewer side effects. A 2017 update meta-analysis of 27 SSRI head-to-head trials covering 3,808 patients found comparable response and remission rates with significantly lower discontinuation due to side effects. There are some catches. Larger, better-designed trials limited specifically to major depression have shown smaller effects vs placebo than older, smaller trials in mixed-severity depression. The honest read is that the effect is real and clinically meaningful for mild to moderate depression, but probably not strong enough on its own for severe depression, where standard antidepressants or combination treatment is the better path.

Direct head-to-head trials with SSRIs. One 12-week randomized trial compared 900 mg/day St. John's Wort to 20 mg fluoxetine in major depression and found St. John's Wort was significantly more effective than fluoxetine and trended toward superiority over placebo. A primary care sertraline trial found similar efficacy to 50-100 mg sertraline at 900-1800 mg/day. Across the trials, the consistent pattern is that St. John's Wort is at least as effective as the SSRI it's compared to, with substantially fewer dropouts.

Drug interactions, the actual mechanism. Hyperforin is a potent activator of the pregnane X receptor (PXR), with a Ki around 27 nM. PXR activation upregulates CYP3A4, CYP2C9, CYP2C19, and the drug efflux pump P-glycoprotein. Since CYP3A4 alone metabolises more than half of all prescription drugs, this means St. John's Wort can drop the blood levels of a huge range of medications, sometimes dramatically. The first major case reports in 2000 involved acute heart transplant rejection in patients on cyclosporine who started St. John's Wort, and similar interactions have since been documented with HIV protease inhibitors, warfarin, digoxin, statins, oral contraceptives, and many cancer drugs. The induction is dose-dependent on the hyperforin content, so low-hyperforin extracts (under about 1%) cause less interaction but may also be less effective.

Oral contraceptive interaction specifically. Multiple studies have confirmed that St. John's Wort accelerates ethinyl estradiol and progestin metabolism, causing breakthrough bleeding and unintended pregnancies in real-world cases. If you're on the combined pill, the mini-pill, or a hormonal IUD/implant that relies on systemic progestin levels, you need a backup barrier method while taking St. John's Wort and for at least two weeks after stopping. This is non-negotiable. The CYP3A4 induction takes about 1-2 weeks to fully establish and roughly the same to wash out.

Women. Beyond the contraceptive interaction, St. John's Wort has been studied directly for premenstrual syndrome and menopausal symptoms. A randomized crossover trial in 36 women with mild PMS using 900 mg/day for two cycles found significant improvement in physical symptoms (pain, cramping) but not in mood symptoms specifically. For perimenopausal hot flashes, a 47-woman pilot trial at 900 mg three times daily over 12 weeks improved menopause-specific quality of life and sleep, with a non-significant trend toward fewer hot flashes. A larger 100-woman trial using a hypericin-standardized extract found significant improvements in hot flash frequency, severity, and duration at 8 weeks. For postmenopausal women with depression specifically, an 80-woman RCT using 990 mg/day for 8 weeks improved both menopausal symptoms and depression scores. The signal across studies is real but moderate. If you're using it for menopausal mood and sleep, expect benefit. If you're using it primarily for hot flashes, it's a reasonable trial but not as proven as oestrogen replacement.

Older adults. One trial in elderly patients at 800 mg/day showed equivalent efficacy to 20 mg fluoxetine in mild-to-moderate depression. The complication in older adults is that they're more likely to be on multiple medications, which dramatically increases the interaction risk. Same dose, much higher caution.

What it doesn't do. It's not effective for severe major depression on its own, the evidence on bipolar depression is weak and there's a real risk of triggering mania or hypomania (so avoid in bipolar disorder), and it shouldn't be used to replace prescription antidepressants without proper medical supervision. The transition from an SSRI to St. John's Wort needs a washout period of at least 2 weeks (5 weeks for fluoxetine due to its long half-life) to avoid serotonin syndrome.

Dosage:

Standard dose: 300 mg three times daily (900 mg/day total) of an extract standardized to 0.3% hypericin and 3-5% hyperforin. This is the dose used in the majority of positive trials

Higher dose: 1800 mg/day (600 mg three times daily) has been used in trials of more severe depression and shows somewhat better effect at the cost of more side effects. Reasonable to escalate to this if 900 mg/day isn't doing enough after 6 weeks

For PMS or menopausal symptoms: 900 mg/day is typical. Some PMS protocols use it luteal-phase only (the two weeks before menstruation) to reduce overall exposure

Onset: Don't expect anything in the first week. Effects start building around week 2 and usually peak around weeks 4-6. If there's nothing by 8 weeks at 900 mg/day, it's unlikely to work for you

Standardization matters. Look for products that specify both hypericin (0.3%) and hyperforin (3-5%) content. Cheap unstandardized products vary wildly in active compound content and trial results don't apply to them. The most-studied branded extracts are WS 5570, LI 160, and Ze 117

With or without food: Either works. Fewer GI side effects when taken with meals

Don't stop abruptly if you've been on it for months. A few case reports describe a withdrawal-like syndrome (headache, nausea, dizziness, fatigue) on sudden discontinuation. Taper over 1-2 weeks

Cycling: Not necessary, but if you're using it long-term, periodic reassessment of whether you still need it makes sense. The evidence base for sustained use beyond 6-12 months is thinner than the short-term data

Here's what you can expect:

Nothing for the first 1-2 weeks. This is the most common reason people give up too early. The mechanism involves slow receptor adaptation, not an acute hit, so subjective improvement takes time to build.

Weeks 2-4, you should start noticing a slow lift. Mood feels less heavy, motivation comes back in small ways, the morning dread softens, sleep starts feeling more restorative. It's not a dramatic shift, more that the floor under your mood quietly rises. People who respond often describe it as feeling more like themselves rather than feeling artificially upbeat.

Weeks 4-8, full effect. If it's going to work for you, this is when it's most apparent. Concentration tends to improve as a knock-on effect of the mood lift. Anxiety often reduces alongside the depression.

If you're using it for PMS, expect benefit within 1-2 cycles. For menopausal symptoms (hot flashes, sleep, mood), expect improvement at 4-8 weeks similar to the depression timeline.

Who doesn't respond: people with severe major depression, people with bipolar disorder, and a meaningful subset of people with major depression where the effect just doesn't materialise. If you're at 900 mg/day for 8 weeks with nothing, escalate to 1800 mg/day for another 4 weeks before concluding it's not working. After that, it's not going to help you and a different approach makes sense.

Side effects & risks:

Drug interactions are the big one. This is the single biggest reason not to take St. John's Wort casually. It induces CYP3A4, CYP2C9, CYP2C19, and P-glycoprotein, which means it can lower blood levels of a huge range of medications including: most antidepressants (SSRIs, SNRIs, tricyclics, MAOIs), oral contraceptives and hormonal birth control, warfarin and other blood thinners, statins, immunosuppressants like cyclosporine and tacrolimus, HIV medications, many cancer drugs (including imatinib and irinotecan), digoxin, theophylline, alprazolam, midazolam, omeprazole, and protease inhibitors. If you're on any prescription medication, check with the prescriber before starting. The induction takes 1-2 weeks to fully kick in and 1-2 weeks to wash out

Serotonin syndrome risk if combined with any other serotonergic drug. This includes all SSRIs and SNRIs, tricyclic antidepressants, MAOIs, tramadol, triptans for migraine, dextromethorphan, ondansetron, and recreational MDMA. Symptoms include agitation, confusion, rapid heart rate, high blood pressure, muscle twitching, sweating, fever, and in severe cases seizures or death. If you're switching from an SSRI, allow a 2-week washout (5 weeks for fluoxetine) before starting St. John's Wort

Photosensitivity is the most common direct side effect, dose-dependent and more likely above 1800 mg/day. Skin and eyes become more sensitive to UV. Wear sunscreen, sunglasses on bright days, and skip if you're doing PUVA or other phototherapy. Fair-skinned people are more affected

GI upset, headache, fatigue, dizziness, dry mouth, restlessness are the typical mild side effects, all reported in roughly 1-3% of users in trials. Generally less common than with SSRIs

Sexual dysfunction can occur but is much less common than with SSRIs. A handful of case reports describe reduced libido and delayed orgasm at higher doses, reversed on stopping. This is one of the genuine advantages over SSRIs

Mania/hypomania risk in people with bipolar disorder. Same as any antidepressant. Avoid if you have bipolar I or II, or a strong family history

Pregnancy and breastfeeding: avoid. Hypericin and hyperforin both pass into breast milk, and there isn't adequate safety data for pregnancy

Anaesthesia: stop St. John's Wort at least 2 weeks before scheduled surgery. The CYP induction can interfere with anaesthetic metabolism and there's at least one case of cardiovascular collapse during anaesthesia attributed to long-term use

Withdrawal-like syndrome on abrupt discontinuation after long-term use, reported in case studies. Taper over 1-2 weeks if you've been on it for more than a few months

🩸

Blood markers

Liver enzymes (ALT, AST), baseline before starting and at 3 months. St. John's Wort itself isn't hepatotoxic, but the induction it causes affects how the liver processes everything else, and a baseline matters if you're combining it with anything else metabolised by the liver.

TSH and thyroid panel, baseline. There are case reports of St. John's Wort elevating TSH, and depression itself can mask underlying thyroid issues. You want to confirm the low mood you're treating isn't actually hypothyroidism.

INR, if you're on warfarin. St. John's Wort lowers warfarin levels and your INR will drift, requiring dose adjustment. Don't combine without close monitoring.

Pregnancy test, if you're on hormonal contraception and have noticed any breakthrough bleeding after starting. Plan a backup barrier method from day one rather than waiting for a problem.

For most people taking St. John's Wort alone for mild-to-moderate depression with no other medications, no specific bloodwork is needed before starting. The people who actually need labs are those on any prescription medication (the prescriber should review interactions and may want drug levels), anyone with a history of liver disease or thyroid issues, women on hormonal birth control (talk to a gynaecologist about a backup), and anyone planning surgery in the next 3 months.

Sold as a dietary supplement in most countries without prescription. In Germany and several other European countries it's a licensed medication for mild-to-moderate depression.